Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (31-40 of 381) with videos related to

Pageof 39
Sort By:
Health Science Reports|June 9, 2022
How to decrease systemic corticosteroids in pemphigus patients under rituximabFabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini, et al.
The Australasian Journal of Dermatology|January 23, 2023
A case of psoriasis and multiple sclerosis succesfully treated with concomitant fingolimod and secukinumabMatteo Megna, Matteo Noto, Gabriella Fabbrocini, et al.
The Journal of Dermatological Treatment|April 18, 2020
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fearsMatteo Megna, Angelo Ruggiero, Claudio Marasca, et al.
Pediatric Dermatology|June 12, 2014
Anterior cervical hypertrichosis: a case report and review of the literatureMatteo Megna, Nicola Balato, Cataldo Patruno, et al.
Italian Journal of Dermatology and Venereology|April 29, 2021
Psoriasis awareness among general population: preliminary results of an online surveyAlessia Villani, Eleonora Cinelli, Gabriella Fabbrocini, et al.
International Journal of Dermatology|July 6, 2018
Acne prevalence in 9 to 14-year-old old patients attending pediatric ambulatory clinics in ItalyMaddalena Napolitano, Giuseppe Ruggiero, Giuseppe Monfrecola, et al.
Journal of Cosmetic Dermatology|October 28, 2021
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5"Luca Potestio, Elisa Camela, Gabriella Fabbrocini, et al.
Dermatologic Therapy|August 8, 2020
Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12/23 and/or anti IL-23: Preliminary data of a real-life 16-week retrospective studyMatteo Megna, Gabriella Fabbrocini, Angelo Ruggiero, et al.
Dermatology Practical & Conceptual|December 9, 2024
Successful Use of Photodynamic Therapy for Treatment of Palbociclib-Induced Periorificial DermatitisDavide Fattore, Giuseppe Lauletta, Matteo Megna, et al.
Dermatologic Therapy|September 27, 2020
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: Report of two casesMatteo Megna, Gabriella Fabbrocini, Maria Ferrillo, et al.
Pageof 39

Showing results (31-40 of 381) with videos related to

Sort By:
Pageof 39
Health Science Reports|June 9, 2022
How to decrease systemic corticosteroids in pemphigus patients under rituximabFabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini, et al.
The Australasian Journal of Dermatology|January 23, 2023
A case of psoriasis and multiple sclerosis succesfully treated with concomitant fingolimod and secukinumabMatteo Megna, Matteo Noto, Gabriella Fabbrocini, et al.
The Journal of Dermatological Treatment|April 18, 2020
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fearsMatteo Megna, Angelo Ruggiero, Claudio Marasca, et al.
Pediatric Dermatology|June 12, 2014
Anterior cervical hypertrichosis: a case report and review of the literatureMatteo Megna, Nicola Balato, Cataldo Patruno, et al.
Italian Journal of Dermatology and Venereology|April 29, 2021
Psoriasis awareness among general population: preliminary results of an online surveyAlessia Villani, Eleonora Cinelli, Gabriella Fabbrocini, et al.
International Journal of Dermatology|July 6, 2018
Acne prevalence in 9 to 14-year-old old patients attending pediatric ambulatory clinics in ItalyMaddalena Napolitano, Giuseppe Ruggiero, Giuseppe Monfrecola, et al.
Journal of Cosmetic Dermatology|October 28, 2021
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5"Luca Potestio, Elisa Camela, Gabriella Fabbrocini, et al.
Dermatologic Therapy|August 8, 2020
Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12/23 and/or anti IL-23: Preliminary data of a real-life 16-week retrospective studyMatteo Megna, Gabriella Fabbrocini, Angelo Ruggiero, et al.
Dermatology Practical & Conceptual|December 9, 2024
Successful Use of Photodynamic Therapy for Treatment of Palbociclib-Induced Periorificial DermatitisDavide Fattore, Giuseppe Lauletta, Matteo Megna, et al.
Dermatologic Therapy|September 27, 2020
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: Report of two casesMatteo Megna, Gabriella Fabbrocini, Maria Ferrillo, et al.
Pageof 39